Transfusion-associated graft-versus-host disease

European Journal of Internal Medicine

Volumn 17, Issue 3, 2006, Pages 151-156

  Oto, Ozgur Akin ^a   Paydas, Semra ^a   Baslamisli, Fikri ^a   Tuncer, Ilhan ^a   Ergin, Melek ^a   Kalakoc, Emre ^a   Disel, Umut ^a   Yavuz, Sinan ^a   Köse, Fatih ^a   Tasova, Yesim ^a  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Blood irradiation; Graft versus host disease; Immunocompetent host; Immunocompromised host; Transfusion

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; BLOOD DERIVATIVE; CORTICOSTEROID; THYMOCYTE ANTIBODY;

ALLERGIC RASH; ANAMNESIS; BLOOD TRANSFUSION; CANCER RADIOTHERAPY; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DERMATITIS; DIAGNOSTIC APPROACH ROUTE; DIARRHEA; FECES ANALYSIS; FEVER; GASTROINTESTINAL TOXICITY; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; JAUNDICE; LABORATORY TEST; MEDICAL EXAMINATION; MEDULLOBLASTOMA; MUCOSA INFLAMMATION; PANCYTOPENIA; RADIATION INJURY; REVIEW; SKIN BIOPSY; TISSUE SECTION; TRANSFUSION ASSOCIATED GRAFT VERSUS HOST DISEASE;

EID: 33646007031     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2005.10.011     Document Type: Review

References (27)

1. Anwar M., and Bhatti F.A. Transfusion associated graft versus host disease. J Ayub Med Coll Abbottabad 15 (2003) 56-58
2. Manno C.S. What's new in transfusion medicine?. Pediatr Clin North Am 43 (1996) 793-808
3. Schroeder M.L. Transfusion-associated graft-versus-host disease. Br J Haematol 117 (2002) 275-287
4. Mori S., Matsushita H., Ozaki K., Ishida A., Tokuhira M., Nakajima H., et al. Spontaneous resolution of transfusion-associated graft-versus-host disease. Transfusion 35 (1995) 431-435
5. Bojanic I., and Cepulic B.G. Transfusion-associated graft-versus-host disease. Lijec Vjesn 126 (2004) 39-47
6. Landi E.P., and de Oliviera J.S. Transfusion-associated graft-versus-host disease guideline in gamma irradiation of blood components. Rev Assoc Med Bras 45 (1999) 261-272
7. Shimoda T. On postoperative erythroderma. Geka 17 (1955) 487-492
8. Hathaway W.E., Githens J.H., Blackburn W.R., Fulgitini V., and Kempe C.H. Aplastic anaemia, histiocytosis and eythrodermia in immunologically deficient children. N Engl J Med 273 (1965) 953-958
9. Aoki Y., Nakamura H., and Sakakibara Y. Probably graft-versus-host reaction following massive blood transfusion in an aged patient with postoperative aortic aneurysm: a case report. Nippon Naika Gakkai Zasshi 73 (1984) 1209-1216
10. Ohto H., and Anderson K.C. Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients. Transfus Med Rev 10 (1996) 31-43
11. Ferrara J., and Deeg H.J. Graft-versus-host disease. N Engl J Med 324 (1994) 667-674
12. Ferrara J.L.M., and Antin J.H. The pathophysiology of graft-versus-host disease. In: Thomas E.D., Blume K.G., and Forman S.J. (Eds). Haematopoietic Cell Transplantation (1999), Blackwell Science, Oxford, UK 305-315
13. Nishimura M., Hidaka N., Akaza T., Tadokoro K., and Juji T. Immunosuppressive effects of chloroquinine: potential effectiveness for treatment of post-transfusion graft-versus-host disease. Transfus Med 8 (1998) 209-214
14. Mayer K. Transfusion of the patient with acquired immunodeficiency syndrome. Arch Pathol Lab Med 114 (1990) 295-297
15. Anderson K.C., Goodnough L.T., Sayers M., Pisciotto P.T., Kurtz S.R., Lane T.A., et al. Variation in blood component irradiation practice: implications for prevention of transfusion-associated graft-versus-host disease. Blood 77 (1991) 2096-2102
16. Popovsky M.A., Benson K., Glassman A.B., Hume H., Oberman H.A., Pisciotto P.T., et al. Transfusion practices in human immunodeficiency virus-infected patients. Transfusion 35 (1995) 612-616
17. Parshuram C., Doyle J., Lau W., and Shemie S.D. Transfusion-associated graft versus host disease. Pediatr Crit Care Med 3 (2002) 57-62
18. Jindal B., Narang A., and Das R. Post-transfusion graft versus host disease-an under recognized entity. Indian Pediatr 38 (2001) 179-183
19. Appleton A.L., Sviland L., Pearson A.D., Wilkes J., Green M.A., and Malcolm A.J. Diagnostic features of transfusion associated graft versus host disease. J Clin Pathol 47 (1994) 541-546
20. Kamide R. Histopathological diagnosis by skin biopsy. Nippon Rinsho 55 (1997) 2259-2261
21. Sohi I., and Jacob S. Transfusion associated graft versus host disease. Indian J Pediatr 72 (2005) 533-535
22. Mori S., Matsushita H., Ozaki K., Ishida A., Tokuhira M., Nakajima H., et al. Spontaneous resolution of transfusion-associated graft-versus-host disease. Transfusion 35 (1995) 431-435
23. Yasukawa M., Shinzaki F., and Hato T. Successful treatment of transfusion-associated graft-versus-host disease. Br J Haematol 86 (1994) 831-836
24. Prince M., Szer J., van der Weyden M.B., Pedersen J.S., Holdsworth R.F., and Whyte G. Transfusion associated graft-versus-host disease after cardiac surgery: response to antithymocyte-globulin and corticosteroid therapy. Aust N Z J Med 21 (1991) 43-46
25. Ryo R., Saigo K., Hashimoto M., Kohsaki M., Yasufuku M., Watanabe N., et al. Treatment of post-transfusion graft-versus-host disease with nafmostat mesilate, a serine protease inhibitor. Vox Sang 76 (1999) 241-246
26. Przepiorka D., Kernan N.A., Ippoliti C., Papadopoulos E.B., Giralt S., Khouri I., et al. Daclizumab, a humized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease. Blood 95 (2000) 83-89
27. BCSH Blood Transfusion Task Force. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. Transfus Med 6 (1996) 261-271